Brief: Inari Medical Says First Patient Enrolled In The DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes Of ClotTriever System In Deep Vein Thrombosis
12/01/2023 13:40
Jan 12 (Reuters) - Inari Medical Inc NARI.O :
* INARI MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN THE
DEFIANCE
TRIAL, RANDOMIZED CONTROLLED TRIAL EVALUATING CLINICAL OUTCOMES
OF THE CLOTTRIEVER® SYSTEM IN DEEP VEIN THROMBOSIS
Source text for Eikon: ID:nGNX6f8Clt
Further company coverage: NARI.O
Recent news on Inari Medical
See all newsJ&J explores bid for Intra-Cellular Therapies, Bloomberg News reports (updated)
U.S. RESEARCH ROUNDUP-GE Healthcare, Summit Materials, Tapestry
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty
U.S. STOCKS ON THE MOVE-Annovis Bio, Hoth Therapeutics, Digital Realty